GSK Financial Statements From 2010 to 2024
| GLAXF Stock | USD 16.51 0.12 0.72% |
Check GSK Plc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GSK Plc's main balance sheet or income statement drivers, such as , as well as many indicators such as . GSK financial statements analysis is a perfect complement when working with GSK Plc Valuation or Volatility modules.
GSK |
GSK plc Company Profit Margin Analysis
GSK Plc's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current GSK Plc Profit Margin | 0.51 % |
Most of GSK Plc's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GSK plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, GSK plc has a Profit Margin of 0.51%. This is 104.55% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The profit margin for all United States stocks is 140.16% lower than that of the firm.
GSK plc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining GSK Plc's current stock value. Our valuation model uses many indicators to compare GSK Plc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GSK Plc competition to find correlations between indicators driving GSK Plc's intrinsic value. More Info.GSK plc is rated # 3 in return on equity category among its peers. It also is rated # 3 in return on asset category among its peers reporting about 0.21 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for GSK plc is roughly 4.75 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the GSK Plc's earnings, one of the primary drivers of an investment's value.About GSK Plc Financial Statements
GSK Plc stakeholders use historical fundamental indicators, such as GSK Plc's revenue or net income, to determine how well the company is positioned to perform in the future. Although GSK Plc investors may analyze each financial statement separately, they are all interrelated. For example, changes in GSK Plc's assets and liabilities are reflected in the revenues and expenses on GSK Plc's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in GSK plc. Please read more on our technical analysis and fundamental analysis pages.
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. Glaxosmithkline Plc is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in GSK Pink Sheet
GSK Plc financial ratios help investors to determine whether GSK Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GSK with respect to the benefits of owning GSK Plc security.